Biocartis Group NV: Results of the extraordinary shareholders' meeting held on 11 September 2017
(Thomson Reuters ONE) -
PRESS RELEASE: REGULATED INFORMATION
11 September 2017, 17:40 CEST
Results of the extraordinary shareholders' meeting held on 11 September 2017
Mechelen, Belgium, 11 September 2017 - Biocartis Group NV (the 'Company' or
'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels:
BCART), held its extraordinary shareholders' meeting in Mechelen today.
The shareholders approved all items on the agenda, namely the appointment of
Herman Verrelst as director of the Company and the approval of a new warrant
plan for Herman Verrelst as the Chief Executive Officer of the Company. Herman
started as Chief Executive Officer of the Company on 31 August 2017.
All documents relating to the extraordinary shareholders' meeting can be
consulted on the website of the Company.
--- END ---
More information:
Renate Degrave
Manager Corporate Communications & Investor Relations Biocartis
email rdegrave(at)biocartis.com
tel +32 15 631 729 | mobile +32 471 53 60 64
About Biocartis
Biocartis (Euronext Brussels: BCART) is an innovative molecular diagnostics
(MDx) company providing next generation diagnostic solutions aimed at improving
clinical practice for the benefit of patients, clinicians, payers and industry.
Biocartis' proprietary MDx Idylla(TM) platform is a fully automated sample-to-
result, real-time PCR (Polymerase Chain Reaction) system that offers accurate,
highly reliable molecular information from virtually any biological sample in
virtually any setting. Biocartis launched the Idylla(TM) platform in September
2014. Biocartis is developing and marketing a rapidly expanding test menu
addressing key unmet clinical needs in oncology and infectious diseases. These
areas represent respectively the fastest growing and largest segments of the MDx
market worldwide. Today, Biocartis offers ten oncology tests and two infectious
disease tests in Europe. More information: www.biocartis.com. Press Photo
Library available here. Follow us on Twitter: (at)Biocartis_.
The Biocartis trademark and logo are trademarks of Biocartis and are used and
registered in Europe. Idylla(TM) is a registered trademark in the United States
and other countries. The Idylla(TM) trademark and logo are trademarks of and
used by Biocartis. This press release is not for distribution, directly or
indirectly, in any jurisdiction where to do so would be unlawful. Any persons
reading this press release should inform themselves of and observe any such
restrictions. Biocartis takes no responsibility for any violation of any such
restrictions by any person. Please refer to the product labeling for applicable
intended uses for each individual Biocartis product. This press release does not
constitute an offer or invitation for the sale or purchase of securities in any
jurisdiction. No securities of Biocartis may be offered or sold in the United
States of America absent registration with the United States Securities and
Exchange Commission or an exemption from registration under the U.S. Securities
Act of 1933, as amended.
Forward-looking statements
This press release may contain forward-looking statements. Such forward-looking
statements are not guarantees of future performance. These forward-looking
statements speak only as of the date of this press release. Biocartis expressly
disclaims any obligation or undertaking to release any updates or revisions to
any forward-looking statements in this press release. You should not place undue
reliance on forward-looking statements.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Biocartis Group NV via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Caledonia Mining Corporation Plc.: Exercise of share options
Datum: 11.09.2017 - 17:40 Uhr
Sprache: Deutsch
News-ID 559460
Anzahl Zeichen: 4542
contact information:
Town:
Mechelen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 323 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biocartis Group NV: Results of the extraordinary shareholders' meeting held on 11 September 2017"
steht unter der journalistisch-redaktionellen Verantwortung von
Biocartis Group NV (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
